GAS RELIEF- simethicone tablet, chewable 
Geri-Care Pharmaceuticals, Corp

----------

gc 791a (799)

Active ingredient (in each tablet)

Simethicone 80 mg

Purpose

Anti-Gas

Uses

for the relief of

Warnings

If pregnant or breast feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• chew thoroughly
• adults and children 12 years and over: take 1-2
tablets as needed after meals and at bedtime. Do
not exceed 6 tablets in 24 hours except under the
advice and supervision of a doctor.
• children under 12 years: ask a doctor

Other information

Inactive ingredients

dextrose, sugar, maltodextrin, microcrystalline cellulose, peppermint flavor, silica, sorbitol, stearic acid

Questions or comments?

1-800-540-3765

package Label

1

GAS RELIEF 
simethicone tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57896-799
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DIMETHICONE (UNII: 92RU3N3Y1O) (DIMETHICONE - UNII:92RU3N3Y1O) DIMETHICONE80 mg
Inactive Ingredients
Ingredient NameStrength
DEXTROSE (UNII: IY9XDZ35W2)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
SORBITOL (UNII: 506T60A25R)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
SUCROSE (UNII: C151H8M554)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize13mm
FlavorPEPPERMINTImprint Code AP019
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57896-799-01100 in 1 BOTTLE; Type 0: Not a Combination Product02/01/2020
2NDC:57896-799-088 in 1 BOTTLE; Type 0: Not a Combination Product02/01/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00202/01/2020
Labeler - Geri-Care Pharmaceuticals, Corp (611196254)
Registrant - Geri-Care Pharmaceuticals, Corp (611196254)

Revised: 10/2023
Document Id: 08a201f2-64a2-552e-e063-6394a90a0686
Set id: b66f63d0-be82-a75b-e053-2a95a90a3f13
Version: 3
Effective Time: 20231026
 
Geri-Care Pharmaceuticals, Corp